通过下一代测序来区分神经病患者中人类JC多重瘤病毒的高度致病性菌株
Eeva Auvinen1, Anni Honkimaa1, Pia Laine2
1Department of Virology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
概括
重组的JC多细胞瘤病毒 (JCPyV) 非编码控制区域 (NCCRs) 在渐进的多焦点白内障 (PML) 患者的大脑和脑脊液中很常见. 下一代测序有助于检测神经变性JCPyV,用于早期诊断.
科学领域:
- 病毒学 病毒学
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
背景情况:
- 简体中文简介:JC多重瘤病毒 (JCPyV) 是一种常见的人类病毒,通常无症状.
- 免疫性损害可以触发JCPyV的重新激活和基因组重组,特别是在非编码控制区域 (NCCR).
- 重组的JCPyV菌株与渐进的多焦点白血脑病 (PML) 有关.
研究的目的:
- 来自PML患者和其他样本类型的JCPyV菌株中的NCCR的特征.
- 调查不同临床和环境样本中重新排列NCCR的流行率.
主要方法:
- 用下一代测序 (NGS) 和生物信息学来分析NCCRs.
- 样本包括PML患者的脑脊液 (CSF) 和脑组织,狼患者的尿液,对照脑组织和废水.
- 在诊断PML样本上进行了定量PCR (qPCR).
主要成果:
- 在一些CSF和组织样本中发现了原型和原型类NCCR.
- 在PML患者样本中,重新排列的NCCR普遍存在: 8/21的CSF和14/16的大脑组织.
- 在C和D块中删除的特征是大多数重新排列的JCPyV菌株;在一些样本中,NCCR是不可放大的.
结论:
- 重组的NCCR在脑组织中占主导地位,在PML患者的CSF中很常见.
- 在CSF或大脑组织中敏感的NGS检测神经向性JCPyV可以帮助早期诊断.
- 改进的诊断可能会导致及时干预和更好的患者结果.
相关概念视频
Next-generation Sequencing
88.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.8K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


